Plasma IgA as a biomarker and IL-21 as a potential therapeutic target in Inflammatory Bowel Disease

被引：0
|
作者：
Tsai, T. [1 ,2 ,3 ]
Hsu, J. L. [4 ,5 ]
机构：
[1] China Med Univ Hosp, Ctr Digest Med, Taichung, Taiwan
[2] Natl Hlth Res Inst, Immunol Res Ctr, Miaoli, Taiwan
[3] China Med Univ, Sch Med, Taichung, Taiwan
[4] China Med Univ, Grad Inst Biomed Sci, Taichung, Taiwan
[5] China Med Univ, Drug Dev Ctr, Taichung, Taiwan
来源：
JOURNAL OF CROHNS & COLITIS | 2025年 / 19卷
关键词：
D O I：
10.1093/ecco-jcc/jjae190.0633
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P0459
引用
收藏
页码：I981 / I982
页数：2
相关论文
共 50 条
  • [1] IL-21 as a therapeutic target in inflammatory disorders
    Di Fusco, Davide
    Izzo, Roberta
    Figliuzzi, Michele M.
    Pallone, Francesco
    Monteleone, Giovanni
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2014, 18 (11) : 1329 - 1338
  • [2] Role of IL-21 in inflammatory bowel disease
    Pallone, Francesco
    Fina, Daniele
    Caruso, Roberta
    Monteleone, Giovanni
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2010, 6 (04) : 537 - 541
  • [3] Evaluating IL-21 as a Potential Therapeutic Target in Crohn's Disease
    Holm, Thomas Lindebo
    Tornehave, Ditte
    Sondergaard, Henrik
    Kvist, Peter Helding
    Sondergaard, Bodil-Cecilie
    Hansen, Lene
    Hermit, Mette Brunsgaard
    Holgersen, Kristine
    Vergo, Sandra
    Frederiksen, Klaus Stensgaard
    Haase, Claus
    Lundsgaard, Dorthe
    GASTROENTEROLOGY RESEARCH AND PRACTICE, 2018, 2018
  • [4] Expression of IL-21 in rats with inflammatory bowel disease
    Mao, J. N.
    Shen, Y. S.
    Luo, X. Y.
    Zhi, Y. L.
    GENETICS AND MOLECULAR RESEARCH, 2015, 14 (04) : 17322 - 17328
  • [5] Psoriasis, from Pathogenesis to Therapeutic Strategies: IL-21 as a Novel Potential Therapeutic Target
    Botti, Elisabetta
    Spallone, Giulia
    Caruso, Roberta
    Monteleone, Giovanni
    Chimenti, Sergio
    Costanzo, Antonio
    CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2012, 13 (10) : 1861 - 1867
  • [6] Legumain Is a Novel Biomarker and Therapeutic Target in Inflammatory Bowel Disease
    Edgington-Mitchell, Laura E.
    Carbone, Simona E.
    Poole, Daniel P.
    Bunnett, Nigel
    GASTROENTEROLOGY, 2016, 150 (04) : S966 - S966
  • [7] Evaluation of plasma IL-21 as a potential biomarker for type 1 diabetes progression
    Schroderus, Anna-Mari
    Poorbaugh, Josh
    McElyea, Samantha
    Beasley, Stephanie
    Zhang, Lin
    Nanto-Salonen, Kirsti
    Rintamaki, Reeta
    Pihlajamaki, Jussi
    Knip, Mikael
    Veijola, Riitta
    Toppari, Jorma
    Ilonen, Jorma
    Benschop, Robert J.
    Kinnunen, Tuure
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [8] The opposing roles of IL-21 and TGFβ1 in chronic inflammatory bowel disease
    MacDonald, Thomas T.
    Bell, Iona
    Monteleone, Giovanni
    BIOCHEMICAL SOCIETY TRANSACTIONS, 2011, 39 : 1061 - 1066
  • [9] Expression of IL-21 and IL-33 in Intestinal Mucosa of Inflammatory Bowel Disease: An Immunohistochemical Study
    Toskas, Alexandros
    Milias, Stefanos
    Delis, Georgios
    Meditskou, Soultana
    Sioga, Antonia
    Papamitsou, Theodora
    DIAGNOSTICS, 2023, 13 (13)
  • [10] IKKα AS A POTENTIAL THERAPEUTIC TARGET FOR THE PREVENTION OF INFLAMMATORY BOWEL DISEASE
    Tang, Joseph
    Papoutsopoulou, Stamatia
    Paul, Andrew
    MacKay, Professor Simon
    Duckworth, Carrie
    Pritchard, Mark
    GUT, 2021, 70 : A126 - A127
12345